Press release
Pediatric Brain Tumors Market Analysis Highlights Growth To $1.92 Billion By 2030 At 6.6% CAGR
Pediatric Brain Tumors Market
Projected Growth and Market Size of the Pediatric Brain Tumors Market
The pediatric brain tumors market is anticipated to expand significantly, reaching a valuation of $1.93 billion by 2030. This growth is expected at a compound annual growth rate (CAGR) of 6.6%, reflecting strong momentum in the field. Factors contributing to this rise include the increasing incidence of pediatric brain tumors, the expanding use of precision medicine, and the integration of artificial intelligence and digital imaging technologies in diagnostics. Additionally, a focus on personalized treatment strategies and growing funding for pediatric neuro-oncology research are playing vital roles in market development. Key trends forecasted for this period involve an increased adoption of precision treatments, enhanced AI-driven diagnostics, broader use of targeted therapies and immunotherapies, a shift toward minimally invasive surgical methods, and boosted investments in research.
The pediatric brain tumors market size has grown strongly in recent years. It will grow from $1.4 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited awareness of pediatric brain tumors, reliance on conventional therapies, low adoption of advanced imaging techniques, lack of specialized pediatric neuro-oncology centers, limited availability of targeted and immunotherapy treatments.
Download a free sample of the pediatric brain tumors market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21248&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Top Companies Leading the Pediatric Brain Tumors Market
Several prominent companies are shaping the pediatric brain tumors market by developing innovative therapies and technologies. These players include Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Novocure, Blueprint Medicines, Oncoheroes Biosciences, Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., Seattle Children's Therapeutics, Pfizer Inc., Merck & Co Inc., Bristol Myers Squibb Company, Sanofi, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Eli Lilly and Company, Day One Biopharmaceuticals Inc., Biodexa Pharmaceuticals, Cellectar Biosciences Inc., ZIOPHARM Oncology Inc., Y‐mAbs Therapeutics Inc., and Neonc Technologies Inc.
Recent Collaborations Highlight Industry Progress
In July 2024, Ipsen, a biopharmaceutical firm based in France, entered into a partnership with Day One Biopharmaceuticals to commercialize tovorafenib for pediatric low-grade glioma (pLGG) outside the United States. This agreement assigns Ipsen the responsibility for regulatory and commercial activities globally. Day One Biopharmaceuticals, headquartered in the US, specializes in treatments for childhood brain tumors such as OJEMDA, which has shown promising results in this niche.
View the full pediatric brain tumors market report:
https://www.thebusinessresearchcompany.com/report/pediatric-brain-tumors-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Trends Shaping the Pediatric Brain Tumors Market
Innovation in treatment approaches is a major focus for companies operating in this market, particularly the development of type II RAF inhibitors. These targeted therapies aim at blocking RAF kinases with mutations that drive tumor growth, especially in certain subtypes of pediatric low-grade glioma. By interfering with aberrant signaling pathways, these inhibitors help prevent tumor proliferation and survival.
A landmark development occurred in April 2024 when Day One Biopharmaceuticals received accelerated FDA approval for OJEMDA (tovorafenib) to treat relapsed or refractory pediatric low-grade glioma in patients six months and older with specific BRAF alterations. This drug marks the first FDA-approved therapy targeting BRAF fusions or mutations in this patient group. The approval was supported by a 51% overall response rate reported in the FIREFLY-1 clinical trial, underscoring the drug's efficacy for children whose tumors have not responded to prior treatments.
Detailed Segmentation of the Global Pediatric Brain Tumors Market
The pediatric brain tumors market is categorized by several key segments to better understand its scope and focus areas:
1) By Tumor Type: Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma or Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors
2) By Treatment Method: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy
3) By Diagnostic Technique: Imaging Techniques, Biopsy, Neurological Exam, Lumbar Puncture
4) By Age Group: Infants, Toddlers, Children, Adolescents
5) By Application Sector: Hospitals and Clinics, Medical Research Centers, Academic Institutes, Other Applications
Further subcategories under tumor types include:
- Gliomas: Low-Grade Gliomas, High-Grade Gliomas
- Mixed Neuronal-Glial Tumors: Gangliogliomas, Dysembryoplastic Neuroepithelial Tumors (DNET)
- Embryonal Tumors: Medulloblastoma, Atypical Teratoid Rhabdoid Tumor (ATRT), Primitive Neuroectodermal Tumors (PNET)
- Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma, Choroid Plexus Carcinoma
- Tumors from Non-Neuroepithelial Tissue: Rhabdomyosarcoma, Ewing's Sarcoma
- Meningeal Tumors: Meningiomas, Hemangiopericytomas
This structured segmentation offers a comprehensive framework to understand the diverse aspects of pediatric brain tumor diagnosis and treatment options, reflecting the complexity and nuanced nature of this market.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pediatric Brain Tumors Market Analysis Highlights Growth To $1.92 Billion By 2030 At 6.6% CAGR here
News-ID: 4612802 • Views: …
More Releases from The Business Research Company
Plasmid DNA Manufacturing Market Study Explores Industry Growth Toward $7.63 Bil …
The plasmid DNA manufacturing market is positioned for remarkable expansion as advancements in biotechnology continue to accelerate. Driven by increasing applications in vaccines and gene therapies, this sector is attracting significant attention from investors and industry leaders alike. Below is an overview of market value projections, leading companies, emerging trends, and segmentation details that outline the current and future landscape of this important industry.
Plasmid DNA Manufacturing Market Size and Growth…
Plant Biotechnology Equipment Market Research Reveals Path To $23.85 Billion By …
The plant biotechnology equipment sector is on the brink of significant expansion, driven by technological innovations and increasing demand for advanced agricultural solutions. This analysis explores the market's anticipated growth, major industry players, key technological trends, and detailed segment insights to provide a clear understanding of its future trajectory.
Projected Market Size and Growth Potential in Plant Biotechnology Equipment
The plant biotechnology equipment market is expected to achieve substantial growth,…
Pigmentation Disorders Treatment Market Demonstrates Long-Term Growth Potential …
The market for pigmentation disorders treatment is poised for significant expansion in the coming years, driven by advances in dermatological care and personalized treatment approaches. As technology and research continue to evolve, this sector is expected to see dynamic growth fueled by new treatment methods and increasing consumer demand for effective skin solutions.
Market Size Outlook and Growth Trajectory for Pigmentation Disorders Treatment
The pigmentation disorders treatment market is anticipated…
Physiological Monitors Market Analysis Highlights Growth To $196.49 Billion By 2 …
An Overview of Growth in the Physiological Monitors Market
The physiological monitors market is set for significant expansion over the coming years. Forecasts predict the market will reach a valuation of $196.49 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.5%. This surge is driven by multiple factors including the rising use of home-based monitoring devices, increased investments in connected healthcare frameworks, advancements in AI-powered…
More Releases for Tumor
Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Carcinoid Tumor Market Size During the Forecast Period?
In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.…
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg
Brain Tumor Foundation
October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis
NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.…
Germ Cell Tumor Treatment Market
The global Germ Cell Tumor Treatment Market is anticipated to achieve a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030.
Understanding Germ Cell Tumors
Germ cell tumors are masses composed of reproductive cells, or germ cells. These cells mature into eggs for individuals assigned female at birth and sperm for those assigned male at birth. The tumors are commonly found in ovaries and testicles, but extragonadal…
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949
This latest report researches the industry structure,…
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights
The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market.
Request Access Global Wilms Tumor Market…
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments…
